FDA Warns Sorin Over Inadequate Incident Reports
The U.S. Food and Drug Administration has warned Italian medical device maker Sorin Biomedica SpA over its failure to adequately submit reports for adverse events related to its defibrillation lead devices...To view the full article, register now.
Already a subscriber? Click here to view full article